Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes인도 인구 게놈에서 코로나19 치료제의 약리유전체학적 풍경Article Published on 2021-07-012022-09-11 Journal: Pharmacogenomics [Category] SARS, 변종, 유전자 메커니즘, 치료제, [키워드] ABCB1 ALB analyzed candidate clinical decision clinically COVID-19 COVID-19 therapeutics covid-19 therapies COVID-19 therapy COVID-19 treatment CYP3A4 Deleterious drug drug-drug interaction Drug–drug interactions drug–drug–gene interactions drugs Evidence Genome Indian population individual inhibitor Interaction material metabolic disorder Numerous overlapped Patient pharmacogenetic pharmacogenomics pharmacogenomics. populations predicted therapy Treatment validation study variant variants whole genome whole genomes with COVID-19 [DOI] 10.2217/pgs-2021-0028 PMC 바로가기 [Article Type] Article